Purpose:
To compare features of endogenous endophthalmitis associated with injection drug use (IDU) to endogenous endophthalmitis from other etiologies.
Methods:
We retrospectively collected data on patients with endogenous endophthalmitis due to IDU or other causes from three academic tertiary care centers over a six-year period. Differences in presenting characteristics, culture results, treatment, and visual acuity (VA) were compared between groups.
Results:
Thirty-eight (34%) patients had IDU-associated endogenous endophthalmitis, while 75 (67%) had endogenous endophthalmitis from other causes. Compared to patients in the non-IDU group, IDU patients were significantly younger, more frequently male, had longer duration of symptoms at diagnosis, and were less likely to have bilateral disease (p<0.05 for all). IDU patients were less likely to have a systemic infection source identified (29% vs 71%, p<0.001) or have positive cultures (47% vs 80%, p<0.001). The IDU group was less likely to be admitted to the hospital (71% vs 92%, p=0.005) and less likely to receive treatment with intravenous antimicrobials (55% vs 83%, p=0.003). VA did not significantly differ between groups.
Conclusions:
Endophthalmitis related to IDU presents in younger patients with less comorbidities and frequently without positive cultures or an identifiable systemic source; therefore, a high index of suspicion is needed to identify this disease.